Related Experiment Video
Updated: Mar 10, 2026
07:40
Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy
Published on: May 26, 2023
1.7K
CARD9 as a potential target in cardiovascular disease
Matthew R Peterson1, Samantha E Haller1, Jun Ren1
1School of Pharmacy, University of Wyoming, College of Health Sciences, Laramie, WY, USA.
Drug Design, Development and Therapy
|December 7, 2016
Summary
Systemic inflammation drives cardiovascular diseases. Targeting caspase recruitment domain family, member 9 (CARD9) in immune cells may offer new therapeutic strategies for these conditions.
Area of Science:
- Cardiovascular pathology
- Immunology
- Molecular biology
Background:
- Systemic inflammation and macrophage infiltration are key factors in cardiovascular diseases like atherosclerosis and heart failure.
- Inflammation triggers a cycle of immune cell activation and cytokine release, leading to tissue damage.
- Cytosolic adaptor CARD9 (caspase recruitment domain family, member 9) is crucial for cytokine secretion in immune cells.
Purpose of the Study:
- To review the role of CARD9 in inflammation-associated cardiovascular pathologies.
- To highlight CARD9 as a potential therapeutic target.
Main Methods:
- Literature review of studies on inflammation, macrophages, and CARD9 in cardiovascular disease.
Main Results:
- CARD9 mediates cytokine secretion in macrophages and other immune cells.
- Its role in inflammatory pathways links it to various cardiovascular conditions.
Conclusions:
- CARD9 is implicated in the pathogenesis of inflammation-related cardiovascular diseases.
- Targeting CARD9 presents a potential therapeutic avenue for managing these conditions.
Related Concept Videos
01:30Coronary Artery Disease I: Introduction
1.4K
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.4K
01:26Coronary Artery Disease II: Pathophysiology
860
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
860
01:27Psychoneuroimmunology: Cardiovascular Disease
644
Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
A key area of focus in PNI is the relationship between stress and coronary...
644
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
603
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
603
01:25Cardiomyopathy I: Introduction and Classification
741
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
741
01:30Cardiomyopathy II: Dilated Cardiomyopathy
695
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
695